Several mechanisms have been proposed to explain the association between diabetes and cancer, such as hyperglycemia, hyperinsulinemia, increased bioactivity of insulin-like growth factor 1, oxidative stress, sex hormone dysregulation, and chronic inflammation [37]
Effectiveness and safety of glucagon-like peptide 1 receptor agonists in patients with type 2 diabetes: evidence from a retrospective real-world study
Brighten: I love that
PlexusDx's Precision Peptide Genetic Test examines these variants and can support more nuanced conversations with your provider about whether a particular GLP-1 formulation, starting dose, or titration schedule aligns with your genetic profile
Originally developed for their glucose-lowering properties in diabetes management, SGLT2 inhibitors have displayed multifaceted effects that may have relevance in the broader field of cancer therapy ( SGLT2 inhibitors have been associated with significant metabolic alterations, including reductions in blood glucose levels, insulin resistance, and body weight
& Marco, J